[1] Lsy T,Covert E,Wilson E,et al.Chronic Hepatitis B Infection:A Review.Jama,2018,319:1802-1813. [2] 武永萍,魏占芳,石栓柱,等.瞬时弹性超声成像在评价乙型肝炎肝纤维化严重程度中的价值.肝脏,2019,24:905-907. [3] Cao J,Chi H,Yu T,et al.Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B:A Prospective Stop Study.J Infect Dis,2017,215:581-589. [4] 李媛媛.慢性乙型肝炎患者血清HBeAg阳性或阴性与HBV DNA水平的关系.贵州医药,2009,33:436-438. [5] Zou Z,Cai Y,Chen Y,et al.Bone marrow-derived mesenchymal stem cells attenuate acute liver injury and regulate the expression of fibrinogen-like-protein 1 and signal transducer and activator of transcription 3.Mol Med Rep,2015,12:2089-2097. [6] 陈美娟,黄海军,戴伊宁,等.血清纤维蛋白原样蛋白1与慢性乙型肝炎肝纤维化程度的相关性.国际流行病学传染病学杂志,2019,46:47-50. [7] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版).中华肝脏病杂志,2015,33:321-340. [8] Feng J,Huang J,Li Z.Kushenin combined with adefovir dipivoxil affects the HBV-DNA load in serum,immune functions and liver functions of patients with chronic hepatitis B.Exp Therap Med,2017,14:5837-5842. [9] 蔡兴龙.乙肝患者血清HBeAg与HBV-DNA定量的相关性分析.河北医学,2019,25:820-823. [10] 程振波,谭黎明,李建英,等.乙型肝炎病毒感染者血清HBV—LP检测意义及其与PreS1抗原、HBVDNA之间关系的研究.实用预防医学,2016,23:487-489. [11] 董博,胡海石,王德景,等.慢性乙型肝炎病毒感染患者血清HBV-LP水平与HBV-DNA及HBeAg的关系及临床意义.实用预防医学,2019,26:490-492. [12] Demchev V,Malana G,Vangala D,et al.Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization.PLoS One,2013,8:e58084. [13] Liu Z,Ukomadu C.Fibrinogen-like protein 1,a hepatocyte derived protein is an acute phase reactant.Biochem Biophys Res Commun,2008,365:729-734. [14] 李娜,李宏斌,朱蕾,等.纤维蛋白原和血常规检测对乙型肝炎的诊断价值.国际病毒学杂志,2016,23:38-40. [15] 董晓玉.联合检测凝血四项、D二聚体、纤维蛋白/纤维蛋白原降解产物对肝病患者的临床价值.血栓与止血学,2016,22:283-285. [16] Milani S,Aliakbarian M,Amouian S.Afibrinogenemia Acquired by Liver Transplant.Exp Clin Transplant,2019,17:692-694. [17] 李娴.生理体液法分析肝病患者的氨基酸研究.天津医科大学,2010. [18] 钟政荣,徐云侠.乙型肝炎患者血清乙型肝炎病毒-DNA与常用血清标志物的相关性分析.蚌埠医学院学报,2015,40:1387-1389. |